Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis

Fig. 3

Survival curves according to A: HR/HER type, B: therapy combination, C: care type, D: treatment pathway

Legend: (A) HR = estrogen and/or progesterone receptor; HER = HER2 receptor; Triple-=estrogen, progesterone and Her2 receptor negative. (B) MT = mistletoe therapy; CHT = chemotherapy and/ or hormone therapy; Surg = surgery; RT = radiotherapy. (C) Out = outpatient; In = inpatient; In + Out = inpatient and outpatient; no data = unknown. (D) COM = chemotherapy and/or hormone therapy and/or surgery and/or radiotherapy, start with MT = patients started with MT with or without any type of COM therapies; start with COM = patients started with any type of COM therapy and complemented or continued with MT later in the course of disease, see Table 3

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us